Skip to content
10-Q/A

Quarterly Report

ArtVentive Medical Group, Inc.

0001056520-15-000183

← back to feed
Filed
Nov 17, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 3, 2015 6.33M sh
Long Term Debt Q3 2015 · Sep 30, 2015 $500K
Long Term Debt Q3 2015 · Dec 31, 2014 $500K
Short Term Debt Q3 2015 · Sep 30, 2015 $500K
Short Term Debt Q3 2015 · Dec 31, 2014 $500K
Cash And Equivalents Q3 2015 · Sep 30, 2015 $53.01K
Cash And Equivalents Q3 2015 · Dec 31, 2014 $104.03K
Stockholders Equity Q3 2015 · Sep 30, 2015 −$557.92K
Stockholders Equity Q3 2015 · Dec 31, 2014 −$1.58M
Current Liabilities Q3 2015 · Sep 30, 2015 $603.87K
Current Liabilities Q3 2015 · Dec 31, 2014 $1.26M
Current Assets Q3 2015 · Sep 30, 2015 $415.77K
Current Assets Q3 2015 · Dec 31, 2014 $151.48K
Total Assets Q3 2015 · Sep 30, 2015 $545.95K
Total Assets Q3 2015 · Dec 31, 2014 $188.97K
Operating Income Q3 2015 · Sep 30, 2015 −$931.45K
Operating Income Q3 2015 · Sep 30, 2015 −$2.78M
Operating Income Q3 2015 · Sep 30, 2014 −$1.58M
Operating Income Q3 2015 · Sep 30, 2014 −$4.89M
Sga Expense Q3 2015 · Sep 30, 2014 $466.87K
Sga Expense Q3 2015 · Sep 30, 2014 $2.12M
Rd Expense Q3 2015 · Sep 30, 2014 $1.11M
Rd Expense Q3 2015 · Sep 30, 2014 $2.77M
Cost Of Revenue Q3 2015 · Sep 30, 2014 $31.87K
Cost Of Revenue Q3 2015 · Sep 30, 2014 $67.5K
Revenue Q3 2015 · Sep 30, 2014 $31.87K
Revenue Q3 2015 · Sep 30, 2014 $67.5K